ViVita Technologies

medical devices

About

BIOMATERIALS ENABLING REGENERATIVE MEDICINE Imagine if there was no need for an organ transplant waiting list or anti-rejection medication because we could use robust and long-lasting organ and tissue replacements from animals without fear of immune rejection. ViVita addresses this need using its patented SPEAR Process to prepare human immune-compatible animal tissues that retain important structural and bioactive features needed for successful transplantation and performance over a patient's lifetime. ViVita's initial product—BARE Patch—will enable a new generation of regenerative replacement heart valves that avoids the limited longevity and need for repeat replacement surgeries associated with current valve bioprostheses.

Technologies

Outlook Weebly Mobile Friendly reCAPTCHA Google Analytics Remote Android AI IoT Node.js

Keywords

regenerative medicine tissue engineering heart valve replacement vascular repair & reconstruction biomaterials medical devices pro-regenerative response self-recognition in grafts medical equipment and supplies manufacturing bioactive preservation medical technology biotechnology healthcare antigen elimination immunological barrier removal immune-compatible tissue b2b antigen quantification spear platform native ecm structure decellularization bare patch stepwise protein chemistry biomaterial scaffolds services organ replacement xenograft scaffolds xenogeneic ecm extracellular matrix hospital & health care

Location

2860 W Covell Blvd, Davis, California, United States, 95616

Related Companies

Companies in the same industry